Zhijian Qian receives UF College of Medicine award

‌

Zhijian Qian, Ph.D., co-leader of the Mechanisms of Oncogenesis research program, received the UF College of Medicine’s Outstanding Research Scientist Award in Basic or Translational Sciences award. Several other Cancer Center members and trainees were also honored during the college's Celebration of Research.

Novel compound shows promise in immunotherapy

‌

UF Health Cancer Center researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer.

Researchers receive pilots for breast cancer studies

‌

Jennifer Fieber, M.D., and Lisa Spiguel, M.D., received UF Health Cancer Center pilot funding to develop interventional treatment trials focused on addressing the needs of women with breast cancer. 

Decoding the genes behind dolastatin 10

‌

UF researchers pinpointed the genetic blueprints behind dolastatin 10, a marine natural product that has led to six FDA-approved cancer drugs since 2011.

Researchers accepted into NCI training program

‌

Lakeshia Cousin, Ph.D., APRN, AGPCNP-BC, and Paul Castillo, M.D., were accepted into the NCI's Early Investigator Advancement Program.

Research Showcase 2024 exhibits record abstracts

‌

This year’s annual Research Showcase on Jan. 31 at the Reitz Union featured 181 posters across our four research programs.

UF Health joins VHL Alliance

‌

UF Health has been recognized as a leader in the treatment of von Hippel-Lindau syndrome, becoming one of only 40 VHL Alliance Clinical Care Centers in the U.S.

Unlocking new frontiers in brain tumor treatment

‌

UF Health currently has the largest portfolio of immunotherapy trials discovered in the lab and advanced to treatment for brain tumor patients of any center in the country.

Partnering for cancer prevention

‌

The UF Health Cancer Center is joining with Sylvester Comprehensive Cancer Center and Moffitt Cancer Center to fund four grants that will bring cancer prevention and detection education to high-risk Florida communities.

The community grants will support new and ongoing cancer screening and prevention projects across the state this year. They include a health fair to help people quit smoking, free mammograms and a big walk-through inflatable colon that shows tumor growth, among other initiatives.

Member spotlight: Jeffrey Harrison

‌

Jeffrey K. Harrison, Ph.D., is a professor and vice chair of education in the department of pharmacology and therapeutics in the UF College of Medicine. His research is focused on understanding the immune-suppressive microenvironment of highly malignant brain tumors such as glioblastoma. The laboratory uses preclinical mouse models of glioma to probe interactions between glioma and immune cells. The long-term goals are directed toward the development of novel approaches to slow glioma progression and overcoming treatment resistance.

Reminder to vote in Doximity

‌

Please take a few minutes to nominate the UF Health Shands Hospital’s Cancer program in the U.S. News & World Report Best Hospitals Expert Opinion Survey, which is now open.

Your support would be greatly appreciated, and it would help to showcase the exceptional care and expertise that our team provides to our patients.

All voting for hospital specialty rankings will be conducted via Doximity. Users should receive emails to complete the survey.

Upcoming Events

6th Annual UF Drug Discovery Symposium

‌

The UF Drug Discovery Symposium, presented by the Center for Natural Products, Drug Discovery & Development and Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is April 15-16.

Send us your news and achievements

We welcome your feedback. Please email us if you have a story idea.